• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, July 17, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Technology

Biomarker Validation Tests Accuracy of Maternal Reports on Infant Smoke Exposure

Bioengineer by Bioengineer
July 17, 2026
in Technology
Reading Time: 3 mins read
0
Biomarker Validation Tests Accuracy of Maternal Reports on Infant Smoke Exposure
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A new biomarker-based analysis is shining a spotlight on a subtle statistical trap in studies that try to reconstruct infants’ exposure to secondhand smoke. The work focuses on maternal reports given either concurrently—around the time exposure occurs—or retrospectively, after months or years have passed. Because such evidence often informs public-health guidance, the reliability of “did your baby breathe smoke?” answers matters.

The central finding is not that every retrospective report is wrong. Instead, the threat lies in a specific pattern of error: mothers who deny that their infants were exposed may be unreliable in a nontrivial subset of cases. In other words, misclassification is asymmetric. Missing exposures are more likely to be missed than falsely reported.

This asymmetry can quietly distort prevalence estimates. If true exposure is undercounted, studies may conclude that fewer infants were harmed—or that harms are milder—than reality suggests. The bias does not just shift numbers; it can also mask developmental risks that researchers are trying to detect in early-life populations.

Using biomarker validation as a reference point, the study evaluates how closely self-report aligns with measurable evidence. Biomarkers provide a more objective snapshot of exposure, allowing researchers to estimate which reporting modes perform better and under what conditions errors emerge. The analysis argues that retrospective designs are particularly vulnerable when researchers treat “no exposure” answers as equally trustworthy.

The implications are broad for long-term cohort studies, where exposure histories often rely on memory. If denial-based misclassification is common, then the analysis framework needs to acknowledge differential error. Otherwise, confidence intervals may look narrow while the underlying exposure distribution is wrong.

The authors suggest that accuracy-improving strategies could reduce bias, including adding contextual measures that corroborate reporting (such as household smoke-related factors). When objective verification is unavailable, triangulating self-report with supporting indicators may offer a practical substitute.

Ultimately, the study reframes a methodological question into a surveillance one: not whether retrospective recall is imperfect, but whether the specific direction of error systematically favors underestimation. That distinction could help reconcile conflicting findings across studies and sharpen estimates of early developmental harm.

If the results generalize, future research should incorporate models that explicitly account for asymmetric misclassification, rather than assuming symmetric reporting error. Doing so may help ensure that policies respond to the exposures infants truly face, not just the exposures researchers can reliably measure through memory.

Subject of Research: Maternal reporting validity of infant secondhand smoke exposure (concurrent vs retrospective) validated with biomarkers
Article Title: Insights into the validity of concurrent and retrospective maternal report of infant smoke exposure using biomarker-based validation.
Article References:

Micalizzi, L., Sokolovsky, A.W., Murphy, C.M. et al. Insights into the validity of concurrent and retrospective maternal report of infant smoke exposure using biomarker-based validation.
Pediatr Res (2026). https://doi.org/10.1038/s41390-026-05238-3

Image Credits: AI Generated
DOI: https://doi.org/10.1038/s41390-026-05238-3
Keywords: Biomarker validation, maternal recall, secondhand smoke exposure, misclassification bias, epidemiologic study design, early-life health outcomes

Tags: asymmetrical misclassification in infant smoke exposure databiomarker validation for infant smoke exposurebiomarker-based comparison of self-reported and measured smoke exposurechallenges in reconstructing infant secondhand smoke exposureearly-life developmental risk detection in secondhand smokeeffects of underreporting on prevalence estimates of infant smoke harmimpact of reporting errors on public health risk assessmentmaternal report accuracy in secondhand smoke studiesreliability of retrospective versus concurrent maternal smoking reportsstatistical bias in passive smoke exposure research

Share12Tweet7Share2ShareShareShare1

Related Posts

Researchers Identify Optimal Conditions for Safer, Longer-Lasting Lithium Metal Batteries

Researchers Identify Optimal Conditions for Safer, Longer-Lasting Lithium Metal Batteries

July 17, 2026
Unraveling Europe’s Energy Crisis with Structural Causal Models

Unraveling Europe’s Energy Crisis with Structural Causal Models

July 17, 2026

Smart Hydrogels and Scaffolds Engineer Microenvironments to Regenerate Tissues

July 17, 2026

All-optical computing advances toward 100-GHz clock speeds

July 17, 2026

POPULAR NEWS

  • Scientists Overcome Antimicrobial Resistance in Bacteria Linked to Cystic Fibrosis

    Scientists Overcome Antimicrobial Resistance in Bacteria Linked to Cystic Fibrosis

    42 shares
    Share 17 Tweet 11
  • Porcine Heart Transplant

    50 shares
    Share 20 Tweet 13
  • 高齢者の骨粗鬆症治療の持続性比較

    51 shares
    Share 20 Tweet 13
  • A multifaceted sensation

    49 shares
    Share 20 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Platelet Reactivity in Older Polymorbid Patients and Effects of 4-Methylcatechol

Researchers Identify Optimal Conditions for Safer, Longer-Lasting Lithium Metal Batteries

Blood DNA test better selects patients for prostate cancer radiopharmaceutical therapy

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.